How two obesity drugs trounced a luxury giant Last week, Danish pharma major Novo Nordisk dethroned French luxury giant LVMH to emerge as Europe’s most valued company. The secret? Humanity’s insatiable appetite for two weight-loss drugs, Ozempic and Wegovy. Mint explains the obesity crisis the world is facing.
How two obesity drugs trounced a luxury giant
- Konuyu başlatan Bilgin
- Başlangıç tarihi